Brief: Ceapro Reports Qtrly Sales of C$2.1 Mln
21/11/2018 14:19
Nov 21 (Reuters) - Ceapro Inc CZO.V :
* CEAPRO INC REPORTS 2018 THIRD QUARTER AND NINE-MONTH
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
* Q3 SALES C$2.1 MILLION VERSUS C$3.6 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nGNX4jd4DK
Further company coverage: CZO.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases